The Almazov Centre has achieved a broad international outreach, in particular through international cooperation in joint research, educational programs and clinical trials.
Today, the Centre collaborates with more than 35 institutions and leading clinics around the world, including those offering educational exchange.
Our major international partners are:
- Karolinska Institute (Sweden): joint projects in the areas of metabolic syndrome, insulin resistance and endothelial dysfunction; training in oncohematology and cytogenetics; exchange of clinical specialists in endovascular surgery and interventional cardiology.
- University of Strasbourg (France): educational and research cooperation for further development of heart and lung transplantation, large-scale implementation of organ transplants into healthcare practice.
- University of Oslo (Norway): joint research, training and conferences in the area of epigenetic regulation of stem cells.
- University Hospital Zurich (Switzerland): the multicenter registry for arrhythmogenic right ventricular dysplasia (ARVC).
- Technical University of Dresden (Germany): clinical and experimental studies in pathophysiology of CVD.
- Institute of Vegetative Physiology of the Charité University Clinic (Germany): joint research in the areas of blood circulation system and neurosurgical pathology.
- University of Verona (Italy): joint fundamental research, in particular in the areas of molecular mechanisms underlying aortic diseases, cardiovascular surgery.
- University of Ferrara (Italy): joint fundamental research, in particular in the areas of molecular mechanisms underlying aortic and myocardial diseases, cardiovascular surgery.
- Liege University (Belgium): joint clinical research and development of methods for studying coma and other states of impaired consciousness.
- Erasmus University Rotterdam (the Netherlands): research in the epidemiology of CVD risk factors.
- Lithuanian University of Health Sciences (Lithuania): research and educational cooperation in basic and clinical medicine.
- Institute of biomedical engineering and technology of Zhejiang University (China): joint research in technologies based on infrared and terahertz scanners, projects within the competencies of the Translational Medicine cluster.
- Tel-Aviv University (Israel): joint research in the areas of endocrine disorders, diabetes mellitus and preeclampsia.
- Bar Ilan University (Israel): joint project “Studying the effect of diet on the microbiome in women with polycystic ovary syndrome”.
- MD Anderson Cancer Centre (USA): planning and implementation of research programs in oncology; online training modules for cancer care providers; clinical and interdisciplinary research in cancer prevention and treatment.
- Broad Institute (USA): research in the epidemiology of CVD risk factors.
- University of Tampere, the Baltic Institute of Finland, FinnMedi: joint initiatives in various areas of translational medicine.
One of the key cooperation projects of the Almazov Center is with the iCMLf (International Chronic Myeloid Leukemia Foundation), Great Britain, under the Emerging Regions Support and Partnership Program (ERSAP) as well as with the European LeukemiaNet supported by the European Union and bringing together doctors, researchers and patients to promote knowledge and joint research on leukemia.
The Almazov Centre is a member of ENEA — European Neuroendocrine Association. The Institute of Endocrinology has been cooperating with ENEA for many years. The result of this cooperation was a joint conference Hyperprolactinemia and Other Endocrine Causes of Infertility in 2017.